نتایج جستجو برای: p2y12 receptor

تعداد نتایج: 591166  

Journal: :Arteriosclerosis, thrombosis, and vascular biology 2012
Lucia Stefanini Yacine Boulaftali Timothy D Ouellette Michael Holinstat Laurent Désiré Bertrand Leblond Patrick Andre Pamela B Conley Wolfgang Bergmeier

OBJECTIVE The goal of this study was to investigate the potential crosstalk between Rap1 and Rac1, 2 small GTPases central to platelet activation, particularly downstream of the collagen receptor GPVI. METHODS AND RESULTS We compared the activation response of platelets with impaired Rap signaling (double knock-out; deficient in both the guanine nucleotide exchange factor, CalDAG-GEFI, and th...

Journal: :Arteriosclerosis, thrombosis, and vascular biology 2012
Kelly A O'Brien T Kent Gartner Nissim Hay Xiaoping Du

OBJECTIVE Integrins mediate platelet adhesion and transmit outside-in signals leading to platelet spreading. Phosphoinositide 3-kinases (PI3Ks) play a critical role in outside-in signaling and platelet spreading; however, the mechanisms of PI3K activation and function in outside-in signaling are unclear. We sought to determine the role of the Akt family of serine/threonine kinases and activatio...

2014
Susanna Amadio Chiara Parisi Cinzia Montilli Alberto Savio Carrubba Savina Apolloni Cinzia Volonté

In the CNS, neuroinflammation occurring during pathologies as amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) is the consequence of an intricate interplay orchestrated by various cell phenotypes. Among the molecular cues having a role in this process, extracellular nucleotides are responsible for intercellular communication and propagation of inflammatory stimuli. This occurs by...

2010
Kade Birkeland David Parra Robert Rosenstein

The use of antiplatelet agents, specifically the thienopyridines, has become a standard of care in the approach to the patient presenting with an acute coronary syndrome. These drugs irreversibly inhibit the platelet by permanently binding to the surface P2Y12 receptor and blocking the downstream fibrinogen cross-linking between platelets, which leads to aggregation and thrombus. However, curre...

2017
Jianjun Sun Qian Xiang Chao Li Zining Wang Kun Hu Qiufen Xie Yimin Cui

The efficacy and safety of novel oral P2Y12 receptor inhibitors (prasugrel and ticagrelor) are subjects of contention in patients with ST-segment elevation myocardial infarction (STEMI) undergoing PCI, and the optimal duration of therapy remains uncertain. We searched PubMed, Embase, Cochrane Library, CNKI, VIP, and WanFang Data to identify randomized controlled trials comparing novel oral P2Y1...

Journal: :Hamostaseologie 2015
M Cattaneo

UNLABELLED In addition to their well characterized and established role in haemostasis and thrombosis, platelets contribute to the pathogenesis of inflammation. Adenine nucleotides are signalling molecules that regulate the function of virtually every cell in the body, by interacting with P2 receptors. Their important role in inflammation is well established. In the last few years, the pro-infl...

2017
Geoffrey Burnstock

Purinergic signalling, i.e., the role of nucleotides as extracellular signalling molecules, was proposed in 1972. However, this concept was not well accepted until the early 1990's when receptor subtypes for purines and pyrimidines were cloned and characterised, which includes four subtypes of the P1 (adenosine) receptor, seven subtypes of P2X ion channel receptors and 8 subtypes of the P2Y G p...

Journal: :Journal of the American College of Cardiology 2005
Benoît Labarthe Pierre Théroux Michaël Angioï Marta Ghitescu

OBJECTIVES This study aimed to explore platelet function tests relevant to the biological effects of clopidogrel that could help the clinical monitoring of drug efficacy. BACKGROUND Clopidogrel selectively inhibits the P2Y12 receptor, the major role of which is stabilization of aggregation, whereas initiation of aggregation depends on activity of both P2Y1 and P2Y12 receptors. METHODS Tests...

2018
Michał J Kubisa Mateusz P Jezewski Aleksandra Gasecka Jolanta M Siller-Matula Marek Postuła

Novel antiplatelet drugs, including ticagrelor, are being successively introduced into the therapy of atherothrombotic conditions due to their superiority over a standard combination of clopidogrel with acetylsalicylic acid in patients with acute coronary syndromes (ACS). A P2Y12 receptor antagonist, ticagrelor, is unique among antiplatelet drugs, because ticagrelor inhibits the platelet P2Y12 ...

Journal: :Journal of the American College of Cardiology 2013
Udaya S Tantry Laurent Bonello Daniel Aradi Matthew J Price Young-Hoon Jeong Dominick J Angiolillo Gregg W Stone Nick Curzen Tobias Geisler Jurrien Ten Berg Ajay Kirtane Jolanta Siller-Matula Elisabeth Mahla Richard C Becker Deepak L Bhatt Ron Waksman Sunil V Rao Dimitrios Alexopoulos Rossella Marcucci Jean-Luc Reny Dietmar Trenk Dirk Sibbing Paul A Gurbel

Dual antiplatelet therapy with aspirin and a P2Y12 receptor blocker is a key strategy to reduce platelet reactivity and to prevent thrombotic events in patients treated with percutaneous coronary intervention. In an earlier consensus document, we proposed cutoff values for high on-treatment platelet reactivity to adenosine diphosphate (ADP) associated with post-percutaneous coronary interventio...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید